We are international
Donate
publications TEXT SIZE   
myeloma minute    back

Myeloma Minute June 5, 2014
06.05.14

June 5, 2014

Share the Minute

Facebook

Tweet!

Clinical Trials

Donate to the IMF

 


x



This week's question: How does the new flow cytometry testing for MRD compare to molecular testing?

UPCOMING EVENTS




Wednesday, June 11, 2014
12 pm ET/ 9 am PT
IMWG Conference Series Livestream "Making Sense of Treatment"


Saturday, June 14, 2014
Myeloma Center Workshop
Minneapolis, Minnesota

Wednesday, June 18, 2014
7 pm ET/ 4 pm PT
Raise Your Voice: Advocacy 202 Webinar

Monday, June 23, 2014
Onyx Team Bike Ride

Thursday, June 26, 2014
7 pm ET/ 4 pm PT
Post ASCO/EHA/IMWG Teleconference
Hosted by Dr. Durie

 

More on Virotherapy for Myeloma: Why Won't Patients Get Infected with the Virus?

In an important blog post, IMF Chairman Dr. Brian Durie shares more information from Dr. Stephen Russell who, along with his team at the Mayo Clinic, treated a myeloma patient with a massive dose of engineered measles virus in a clinical trial. Many are wondering: if this virus is so strong that it can destroy myeloma, why isn't it causing a raging case of measles? CLICK HERE to read Dr. Durie's blog with the enlightening answer.

x
IMWG Summit Preview

The IMF will host the 5th Annual International Myeloma Working Group (IMWG) Summit next week in Milan, Italy. New myeloma research will be front and center, and will be shared directly from Milan during the IMWG Conference Series, "Making Sense of Treatment," which will be live streamed on June 11th. Other key events will include the presentation of the Robert A. Kyle Lifetime Achievement Award to Dr. Antonio Palumbo and the 2nd annual Global Myeloma Alliance (GMA) Summit. Follow news live from the IMWG Summit on Twitter using the hashtag #IMWG14 and stay tuned for next week's edition of the Myeloma Minute for more news from the Summit.

x
IMF's Michael S. Katz Wins ASCO's Partners in Progress Award

Congratulations to IMF Executive Board member Michael S. Katz, who won the American Society of Clinical Oncology's (ASCO) 2014 Partners in Progress Award! It is awarded annually to a patient advocate who has made "significant contributions in the field of cancer care." Since he began volunteering with the IMF in 1990, the year he was diagnosed with myeloma, Mike has made countless contributions to the field of myeloma. Mike credits IMF President and Co-Founder Susie Novis for inspiring his start as a patient advocate. "She brought me in to help IMF set up its database and [introduced me to] the work the Foundation was doing with seminars for patients and their families. Being in a room with 200 patients with myeloma and informing them that [they] can live well with this disease over the long term is incredible," said Mike. READ MORE

x
Alert: Proper Procedure for Subcutaneous Velcade Injections

The IMF has received reports that some myeloma patients are receiving injections of subcutaneous Velcade (bortezomib) incorrectly. CLICK HERE to view a video that shows exactly how subcutaneous Velcade should be administered—only in the abdomen or thighs.

x
   
 
Join Our Mailing List
12650 Riverside Drive, Suite 206 | North Hollywood, CA 91607-3421
IMF Hotline: 800-452-2873 or 818-487-7455
Privacy Policy | Unsubscribe 
www.myeloma.org

 related articles